Skip to main content
Log in

Should All Elderly People Receive Folate Supplements?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Although it was initially thought that folate deficiencies are uncommon in the elderly, the use of the plasma total homocysteine concentration as a metabolic marker of folate status is changing this attitude. Plasma homocysteine measurements in epidemiological studies suggest that subclinical folate deficiencies are common in various populations, including the elderly. The clinical consequences of a compromised folate status may include increased coronary heart disease and cancer risk, and an association between folate deficiency and neuropsychiatric illness has been reported. Although a suboptimal folate status is associated with at least 2 major chronic diseases, it would be premature to recommend folate supplements to all elderly people. We still lack evidence that a suboptimal folate status is causally involved in the pathogenesis of the abovementioned disorders. Furthermore, cancer and the cardiovascular diseases are chronic conditions and it may be too late to use folate supplementation as preventative measures in elderly persons. However, folate supplementation should be considered in elderly people with elevated plasma total homocysteine concentrations and proven cardiovascular disease, in elderly patients treated with drugs known to induce a folate deficiency, and in those who experience neuropsychiatric disorders. Cyanocobalamin (vitamin B12) deficiencies should be excluded before folate supplementation is commenced; if in doubt, it may be safer to supplement folate and vitamin B12 together. The daily folate supplement should be at least 0.5 mg/day and it should never be used as a surrogate for a diet rich in fruit and vegetables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gunter EW, Bowman BA, Caudill SP, et al. Results of an international round robin for serum and whole blood folate. Clin Chem 1996; 42: 1689–94

    PubMed  CAS  Google Scholar 

  2. Senti FR, Pilch SM. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES ll). J Nutr 1985; 115: 1398–402

    PubMed  CAS  Google Scholar 

  3. Girdwood RH, Thomson AD, Williamson J. Folate status in the elderly. BMJ 1967; 2: 670–3

    Article  PubMed  CAS  Google Scholar 

  4. National Academy of Sciences. Recommended dietary allowances. 9th ed. Washington, DC: National Academy of Sciences, 1980

    Google Scholar 

  5. Garry PJ, Goodwin JS, Hunt WC. Folate and vitamin B-12 status in a healthy elderly population. J Am Geriatr Soc 1984; 32: 719–26

    PubMed  CAS  Google Scholar 

  6. Rosenberg TH, Bowman BB, Cooper BA, et al. Folate nutrition in the elderly. Am J Clin Nutr 1982; 36: 1060–6

    PubMed  CAS  Google Scholar 

  7. National Academy of Sciences. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989

    Google Scholar 

  8. Craig GM, Elliot C, Hughes KR. Masked vitamin B-12 and folate deficiency in the elderly. Br J Nutr 1985; 54: 613–9

    Article  PubMed  CAS  Google Scholar 

  9. Ubbink JB, Van der Merwe A, Delport R, et al. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 1996; 98: 177–84

    Article  PubMed  CAS  Google Scholar 

  10. Stipanuk MH. Metabolism of sulfur-containing amino acids. Ann Rev Nutr 1986; 6: 179–209

    Article  CAS  Google Scholar 

  11. Ubbink JB, Vermaak WJH, Van der Merwe A, et al. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124: 1927–33

    PubMed  CAS  Google Scholar 

  12. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693–8

    Article  PubMed  CAS  Google Scholar 

  13. Ubbink JB, Vermaak HJH, van der Merwe A, et al. Effective homocysteine metabolism may protect South African Blacks against coronary heart disease. Am J Clin Nutr 1995; 62: 802–8

    PubMed  CAS  Google Scholar 

  14. Joosten E, Vandenberg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12, folate and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468–76

    PubMed  CAS  Google Scholar 

  15. Naurath HJ, Joosten E, Riezler R, et al. Effects of vitamin B-12, folate, and vitamin B-6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995; 346: 85–9

    Article  PubMed  CAS  Google Scholar 

  16. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286–91

    Article  PubMed  CAS  Google Scholar 

  17. Stampfer MJ, Malinow R, Willet WC, et al. Aprospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877–81

    Article  PubMed  CAS  Google Scholar 

  18. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775–81

    Article  PubMed  CAS  Google Scholar 

  19. Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049–57

    Article  PubMed  CAS  Google Scholar 

  20. Morrison EI, Schaubel D, Desmeules M, et al. Serum folate and risk of fatal coronary heart disease. JAMA 1996; 275: 1893–6

    Article  PubMed  CAS  Google Scholar 

  21. Mason JB. The modulation of colorectal carcinogenesis by alterations in folate status: epidemiology and pathobiology. In: Mato JM, Caballero A, editors. Third workshop on methionine metabolism. Molecular mechanism and clinical implications. Consejo Superior de Investigaciones Cientificas (CSIC); 1996; Madrid

    Google Scholar 

  22. Freudenheim JL, Graham S, Marshall JR, et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991; 20: 368–74

    Article  PubMed  CAS  Google Scholar 

  23. Benito E, Stiggelbout A, Bosch FX, et al. Nutritional factors in colorectal cancer risk: a case control study in Majorca. Int J Cancer 1991; 49: 161–7

    Article  PubMed  CAS  Google Scholar 

  24. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and the risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875–84

    Article  PubMed  CAS  Google Scholar 

  25. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine-low-folate diets, and the risk of colon cancer in men. J Natl Cancer Inst 1995; 87: 265–73

    Article  PubMed  CAS  Google Scholar 

  26. Thornton WE, Thornton BP. Geriatric mental function and serum folate: a review and survey. South Med J 1977; 70: 919–22

    Article  PubMed  CAS  Google Scholar 

  27. Ortega RM, Manas LR, Andres P, et al. Functional and psychic deterioration in elderly people may be aggravated by folate deficiency. J Nutr 1996; 126: 1992–9

    PubMed  CAS  Google Scholar 

  28. Anonymous. Folic acid and the nervous system. Lancet 1976; II: 836

  29. Botez MI, Cadotte M, Beaulieu R, et al. Neurologic disorders responsive to folic acid therapy. Can Med Assoc J 1976; 115: 217–23

    PubMed  CAS  Google Scholar 

  30. Edeh J, Toone BK. Antiepileptic therapy, folate deficiency and psychiatric morbidity: a general practice survey. Epilepsia 1985; 26: 434–40

    Article  PubMed  CAS  Google Scholar 

  31. Reynolds RH. Methylation and mood. Lancet 1984; II: 196–8

    Article  Google Scholar 

  32. Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336: 392–5

    Article  PubMed  CAS  Google Scholar 

  33. Ubbink JB. Will an increase in dietary folate intake reduce the incidence of cardiovascular disease? Nutr Rev 1996; 54: 213–6

    Article  PubMed  CAS  Google Scholar 

  34. Allen RH, Stabler SP, Savage DG, et al. Diagnosis of cobalamin deficiency 1: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 90–8

    Article  PubMed  CAS  Google Scholar 

  35. Flodin NW. The pharmacology of micronutrients: current topics in nutrition and disease. Vol. 20. New York: Alan R. Liss, 1988: 161

    Google Scholar 

  36. Doscherholmen A, Hagen PS. A dual mechanism of vitamin B12 plasma absorption. J Clin Invest 1957; 36: 1551–7

    Article  PubMed  CAS  Google Scholar 

  37. Hillman RS. Hematopoietic agents, growth factors, minerals and vitamins. In: Hardman JC, Limberd LE, editors. Goodman and Gillman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996

    Google Scholar 

  38. Morgan SL, Baggott JE, Vaughn WV, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. Ann Intern Med 1994; 121: 833–41

    PubMed  CAS  Google Scholar 

  39. Homocysteine Lowering Trialists’ Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 361: 894–8

    Google Scholar 

  40. Guttormsen AB, Ueland PM, Nygard O, et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinaemia (> 40 µmol/L). The Hordaland Homocysteine Study. J Clin Invest 1996; 98: 2174–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johan B. Ubbink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ubbink, J.B. Should All Elderly People Receive Folate Supplements?. Drugs & Aging 13, 415–420 (1998). https://doi.org/10.2165/00002512-199813060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199813060-00001

Keywords

Navigation